Paper Details
- Home
- Paper Details
Drug-drug interactions with imatinib: An observational study.
Author: Bondon-GuittonEmmanuelle, BourrelRobert, ChebaneLeila, DespasFabien, Lapeyre-MestreMaryse, MontastrucJean-Louis, RousseauVanessa, RécochéIsabelle
Original Abstract of the Article :
Many patients treated with imatinib, used in cancer treatment, are using several other drugs that could interact with imatinib. Our aim was to study all the drug-drug interactions (DDIs) observed in patients treated with imatinib.We performed 2 observational studies, between the 1st January 2012 and...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059082/
データ提供:米国国立医学図書館(NLM)
Drug-Drug Interactions with Imatinib: A Cautionary Tale
The world of drug interactions is like a vast and intricate desert, where even the most experienced traveler can encounter unforeseen hazards. This study, like a team of pharmacists carefully navigating this complex terrain, investigates the potential drug-drug interactions (DDIs) that can occur when imatinib, a cancer treatment drug, is used in combination with other medications. The authors, armed with their knowledge of drug interactions, analyze data from French health insurance databases and pharmacovigilance reports, seeking to identify common DDIs and their potential implications.Imatinib: A Drug with Potential Interaction Risks
The authors' findings, like a warning sign in the desert, highlight the significant risk of DDIs when imatinib is used. They identify paracetamol, proton pump inhibitors, dexamethasone, and levothyroxine as common medications that can interact with imatinib, emphasizing the need for careful monitoring and dose adjustments. This study is a reminder that even seemingly innocuous medications can have unexpected interactions when combined with other drugs.A Call for Vigilance in Drug Prescribing
The authors emphasize the importance of vigilance in drug prescribing, especially for patients taking imatinib. This research is like a guidebook for desert travelers, providing valuable information on how to avoid potential hazards. They advocate for close monitoring of patients on imatinib, recommending specific dose adjustments and avoiding certain medications to minimize the risk of DDIs.Dr. Camel's Conclusion
This study is a critical reminder of the importance of understanding drug-drug interactions. The authors highlight the potential risks of DDIs involving imatinib, emphasizing the need for careful monitoring and dose adjustments. This research is a call to action, urging clinicians to prioritize patient safety by being aware of potential interactions and taking appropriate precautions. It's a reminder that the desert of drug interactions is vast and complex, requiring meticulous attention and careful navigation.Date :
- Date Completed 2017-02-09
- Date Revised 2021-01-09
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.